IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 335 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $225,802 | +5.9% | 4,978 | -4.2% | 0.00% | 0.0% |
| Q2 2023 | $213,274 | -74.8% | 5,198 | -76.8% | 0.00% | -75.0% |
| Q4 2022 | $846,539 | -99.9% | 22,413 | -51.1% | 0.01% | -27.3% |
| Q3 2022 | $1,015,014,000 | +120020.0% | 45,850 | +100.8% | 0.01% | +22.2% |
| Q2 2022 | $845,000 | -3.4% | 22,831 | -3.3% | 0.01% | 0.0% |
| Q1 2022 | $875,000 | +46.1% | 23,617 | +20.0% | 0.01% | +50.0% |
| Q4 2021 | $599,000 | -36.1% | 19,681 | -29.5% | 0.01% | -33.3% |
| Q3 2021 | $937,000 | +2.9% | 27,924 | +22.2% | 0.01% | -10.0% |
| Q2 2021 | $911,000 | -11.7% | 22,846 | -0.5% | 0.01% | -23.1% |
| Q1 2021 | $1,032,000 | – | 22,950 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
| Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
| M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
| Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
| Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
| Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
| Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
| BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
| Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
| Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |